Civic Capsule 7.5 mg (Meloxicam)

Adult dose

Acute exacerbation of osteoarthritis (degenerative arthritis): Adults: Administer 7.5mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15mg daily if necessary. Rheumatoid arthritis and ankylosing spondylitis: Adults: Administer 15mg of this drug orally once daily. The dose may be reduced to 7.5mg daily according to response to treatment. Do not administer more than 15mg of this drug per day. Take it with water or another beverage during a meal. For older adults or patients at increased risk of adverse reactions, treatment is generally initiated at a dose of 7.5mg daily. Patients with severe renal failure undergoing hemodialysis should not receive more than 7.5mg daily.

This medicine may increase the risk of gastrointestinal bleeding in individuals who regularly consume more than three alcoholic drinks a day, so it is essential to consult with a doctor or pharmacist. This medication can affect the cardiovascular system and may increase the risk of serious thrombotic reactions such as myocardial infarction or stroke; therefore, caution is needed in patients with cardiovascular diseases or risk factors. It may affect the gastrointestinal tract, potentially causing serious adverse reactions, such as gastrointestinal bleeding, ulcers, or perforation, so patients with a history of gastrointestinal diseases should exercise particular caution. Severe allergic reactions or dermatitis may occurrarely, and immediate discontinuation is necessary if any skin abnormalities are observed. It can affect kidney function, potentially leading to interstitial nephritis or renal failure, so careful monitoring is required for patients with kidney diseases. Abnormal liver function may occur, necessitating regular monitoring of liver function in patients with liver diseases or abnormal liver function test results. This medication may reduce fertility, hence women planning to become pregnant should avoid use, and it should also not be used by pregnant or nursing women. This drug should not be administered to patients with specific allergic reactions or significant health problems such as gastrointestinal bleeding, severe liver dysfunction, heart failure, or severe hypertension. Elderly patients, those with gastrointestinal diseases, skin adverse reactions, or impaired kidney or liver function should use this medication with particular caution, and caution is also needed while driving or operating machinery. This drug has many drug interactions, and caution should be exercised, especially when combined with anticoagulants, lithium, methotrexate, diuretics, and antihypertensive agents, consulting a specialist for careful management. In the case of overdose, symptoms may include drowsiness, nausea, vomiting, gastrointestinal bleeding, and in severe cases, renal failure, liver failure, or coma, so immediate medical attention should be sought. This drug should be kept out of the reach of children and stored sealed in its original container.

• Gastrointestinal bleeding
• cardiovascular thrombotic events
• myocardial infarction
• stroke
• gastric or intestinal bleeding
• ulcers
• perforation
• desquamative dermatitis
• mucous membrane syndrome
• toxic epidermal necrolysis

This medication is sensitive to light and should be stored in a tightly sealed container that protects from light. It is recommended to store the drug at room temperature between 1°C and 30°C. This will help maintain the effectiveness of the drug and prevent deterioration.

Appearance

A hard capsule filled with a light yellow content, with green opaque upper and lower parts.

Package unit

30 capsules/bottle, 300 capsules/bottle